Open in Screener

MYGN

Myriad Genetics, Inc

Feb 27 • 04:00PM ET

4.61

-0.25 -5.14 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH INCY QGEN EXAS NTLA CRSP CDNA TXG TWST

| Held by: IJR VTI XBI IWM VXF SPSM IWN IBB IJS FNDA

Index	RUT	P/E	-	EPS (ttm)	-3.95	Insider Own	4.87%	Shs Outstand	93.50M	Perf Week	7.46%
Market Cap	431.07M	Forward P/E	32.84	EPS next Y	0.14	Insider Trans	2.35%	Shs Float	88.95M	Perf Month	-19.41%
Enterprise Value	491.27M	PEG	0.57	EPS next Q	-0.07	Inst Own	102.17%	Short Float	12.11%	Perf Quarter	-41.72%
Income	-365.90M	P/S	0.52	EPS this Y	-23.34%	Inst Trans	0.23%	Short Ratio	10.08	Perf Half Y	-22.26%
Sales	824.50M	P/B	1.17	EPS next Y	205.17%	ROA	-42.20%	Short Interest	10.78M	Perf YTD	-25.04%
Book/sh	3.94	P/C	2.88	EPS next 5Y	57.22%	ROE	-68.45%	52W High	11.64 -60.40%	Perf Year	-58.32%
Cash/sh	1.60	P/FCF	-	EPS past 3/5Y	-41.67% -8.03%	ROIC	-64.09%	52W Low	3.76 22.61%	Perf 3Y	-75.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	6.72% 5.24%	Gross Margin	67.05%	Volatility	12.29% 7.15%	Perf 5Y	-84.88%
Dividend TTM	-	EV/Sales	0.60	EPS Y/Y TTM	-181.57%	Oper. Margin	-8.22%	ATR (14)	0.36	Perf 10Y	-87.00%
Dividend Ex-Date	-	Quick Ratio	2.26	Sales Y/Y TTM	-1.56%	Profit Margin	-44.38%	RSI (14)	37.15	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.49	EPS Q/Q	81.84%	SMA20	-4.53%	Beta	1.90	Target Price	7.39
Payout	-	Debt/Eq	0.57	Sales Q/Q	-0.38%	SMA50	-18.97%	Rel Volume	1.86	Prev Close	4.86
Employees	2700	LT Debt/Eq	0.55	Earnings	Feb 23 AMC	SMA200	-23.90%	Avg Volume	1.07M	Price	4.61
IPO	Oct 06, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	368.46% 1.14%	Trades		Volume	1,986,309	Change	-5.14%

Date	Action	Analyst	Rating Change	Price Target Change
May-21-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$6
May-08-25	Downgrade	Wolfe Research	Outperform → Peer Perform
May-07-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$6
Apr-09-25	Downgrade	Guggenheim	Buy → Neutral
Mar-12-25	Upgrade	Piper Sandler	Neutral → Overweight	$11.50 → $12.50
Feb-12-25	Initiated	Craig Hallum	Buy	$29
Dec-10-24	Initiated	UBS	Neutral	$18
Dec-09-24	Downgrade	Leerink Partners	Outperform → Market Perform	$30 → $21
Sep-19-24	Initiated	Morgan Stanley	Equal-Weight	$32
Aug-28-24	Initiated	Wells Fargo	Overweight	$35
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$29
Jun-03-24	Resumed	Jefferies	Underperform	$20
May-08-24	Upgrade	Leerink Partners	Market Perform → Outperform	$25 → $35
Dec-21-23	Resumed	Piper Sandler	Neutral	$23
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$20
Dec-14-23	Initiated	Guggenheim	Buy	$23
Dec-13-23	Initiated	Wolfe Research	Outperform	$28
Jul-05-23	Resumed	JP Morgan	Underweight	$18
May-23-23	Upgrade	Goldman	Sell → Buy	$18 → $25
Jan-18-23	Upgrade	Raymond James	Mkt Perform → Outperform	$25

Show Previous Ratings

Feb-24-26 11:25AM	Why Myriad Genetics (MYGN) Stock Is Trading Up Today (StockStory)
09:00AM	Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad's Precise MRD, Prolaris, and MyRisk tests (GlobeNewswire)
08:30AM	Myriad Genetics, Inc. Q4 2025 Earnings Call Summary (Moby)
07:45AM	MYGN Stock Up on Q4 Earnings and Revenue Beat, Gross Margin Down (Zacks)
12:02AM	Myriad Genetics Inc (MYGN) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... (GuruFocus.com)
08:00PM	Loading…
Feb-23-26 08:00PM	Here's What Key Metrics Tell Us About Myriad (MYGN) Q4 Earnings (Zacks)
07:25PM	Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:18PM	Myriad Genetics Q4 Earnings Call Highlights (MarketBeat)
04:52PM	Myriad: Q4 Earnings Snapshot (Associated Press Finance)
04:21PM	Myriad Genetics's (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22% (StockStory)
04:05PM	Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution (GlobeNewswire)
12:07PM	Exact Sciences Stockholders Approve Abbott Merger as Executive Pay Proposal Fails at Special Meeting (MarketBeat)
Feb-19-26 09:15AM	FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test (GlobeNewswire)
Feb-18-26 09:15AM	Ahead of Myriad (MYGN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-16-26 04:15PM	Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 (GlobeNewswire)
08:02PM	Loading…
Feb-12-26 08:02PM	Zydus Lifesciences Ltd (BOM:532321) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com) -6.60%
Feb-10-26 10:07PM	Quest Diagnostics Q4 Earnings Call Highlights (MarketBeat)
Jan-27-26 08:50AM	Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data (GlobeNewswire)
Jan-21-26 11:36PM	2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm (StockStory)
Jan-13-26 07:30AM	TEM's Collab for Oncology Patient Population Is Gaining Attention (Zacks) -5.63%
Jan-12-26 08:30AM	Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance (GlobeNewswire)
Jan-05-26 04:15PM	Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.19%
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
Dec-22-25 03:01PM	Myriad Genetics (MYGN) Stock Trades Up, Here Is Why (StockStory)
Dec-09-25 02:16PM	Why Myriad Genetics (MYGN) Stock Is Up Today (StockStory)
09:00AM	Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium (GlobeNewswire)
Dec-08-25 11:03PM	Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Dec-04-25 11:30AM	Why Is Exelixis (EXEL) Up 9% Since Last Earnings Report? (Zacks)
Dec-03-25 11:30AM	Why Is Myriad (MYGN) Up 8.7% Since Last Earnings Report? (Zacks)
Dec-02-25 11:34PM	1 Healthcare Stock with Promising Prospects and 2 We Question (StockStory)
12:36PM	Loading…
Dec-01-25 12:36PM	Why Myriad Genetics (MYGN) Stock Is Trading Lower Today (StockStory) -7.47%
Nov-25-25 04:15PM	Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health (GlobeNewswire)
Nov-24-25 07:00PM	Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know (StockStory)
Nov-19-25 12:45PM	Why Myriad Genetics (MYGN) Stock Is Up Today (StockStory)
Nov-18-25 10:36PM	Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment (StockStory)
Nov-17-25 08:55AM	How Did Tempus AI Power Its Move to Positive EBITDA in Q3? (Zacks)
Nov-11-25 09:00AM	Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences (GlobeNewswire)
Nov-10-25 08:30AM	Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk Hereditary Cancer Test to Support Evolving Clinical Needs (GlobeNewswire)
12:31AM	The Top 5 Analyst Questions From Myriad Genetics's Q3 Earnings Call (StockStory)
Nov-06-25 08:30AM	Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference (GlobeNewswire)
Nov-04-25 11:56AM	Why Myriad Genetics (MYGN) Stock Is Down Today (StockStory) -21.03%
08:46AM	MYGN Q3 Deep Dive: Oncology Growth and Product Launches Offset Market Headwinds (StockStory)
12:00AM	Myriad Genetics Inc (MYGN) Q3 2025 Earnings Call Highlights: Navigating Revenue Decline with ... (GuruFocus.com)
Nov-03-25 07:00PM	Myriad (MYGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:40PM	Myriad Genetics (MYGN) Reports Break-Even Earnings for Q3 (Zacks)
05:27PM	Myriad Genetics's (NASDAQ:MYGN) Q3 Earnings Results: Revenue In Line With Expectations But Stock Drops (StockStory)
04:40PM	Myriad: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution (GlobeNewswire)
Nov-01-25 11:07PM	What To Expect From Myriad Genetics's (MYGN) Q3 Earnings (StockStory)
Oct-31-25 09:28AM	Earnings To Watch: Myriad Genetics Inc (MYGN) Reports Q3 2025 Result (GuruFocus.com)
09:05AM	New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner (GlobeNewswire)
Oct-27-25 04:15PM	Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Oct-17-25 12:36AM	2 Unpopular Stocks That Deserve a Second Chance and 1 That Underwhelm (StockStory)
Oct-14-25 08:00AM	Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel (GlobeNewswire)
Oct-10-25 03:51PM	Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know (StockStory)
Oct-08-25 08:20AM	Hologic Expands Panther Fusion's Menu With Diagnostic Innovation (Zacks)
Oct-02-25 09:15AM	Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker (Zacks)
Oct-01-25 11:31PM	A Look Back at Therapeutics Stocks' Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack (StockStory) +6.92%
Sep-23-25 08:01AM	Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy (PR Newswire)
Sep-17-25 12:34AM	3 Small-Cap Stocks That Concern Us (StockStory)
Sep-16-25 08:20AM	Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now? (Zacks)
Sep-08-25 08:14AM	MYGN Stock Might Gain on The Lancet Study Backing Precise MRD (Zacks)
Sep-05-25 10:56AM	MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? (Zacks)
12:39AM	3 Russell 2000 Stocks with Open Questions (StockStory)
Sep-04-25 07:00PM	Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology (GlobeNewswire)
Sep-03-25 04:30PM	New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression (GlobeNewswire)
Aug-27-25 04:05PM	Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences (GlobeNewswire)
Aug-20-25 02:00AM	ANGLE Announces Collaboration with Myriad Genetics (ACCESSWIRE)
Aug-18-25 08:30AM	Myriad Genetics Appoints Ben Wheeler Chief Financial Officer (GlobeNewswire)
12:36AM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Aug-13-25 08:00AM	New Myriad Genetics Survey Uncovers Women Fear Screenings-But Feel Reassured by the Results (GlobeNewswire)
12:11AM	Myriad Genetics's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
12:10AM	MYGN Q2 Deep Dive: Oncology Strategy Shift and Product Execution Shape Guidance (StockStory)
Aug-12-25 10:00AM	RxPreferred Benefits Expands Executive Leadership Team with Strategic Appointment and Key Promotions (PR Newswire)
12:03AM	3 Reasons MYGN is Risky and 1 Stock to Buy Instead (StockStory)
Aug-11-25 07:45AM	TD Cowen Maintained a Hold Rating on Myriad Genetics (MYGN) (Insider Monkey)
Aug-06-25 04:57PM	CareDx Announces Appointment of Nathan Smith as Chief Financial Officer (Business Wire) +46.51% +7.58%
01:11PM	Why Is Myriad Genetics (MYGN) Stock Soaring Today (StockStory)
Aug-05-25 06:30PM	Compared to Estimates, Myriad (MYGN) Q2 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:52PM	Myriad: Q2 Earnings Snapshot (Associated Press Finance)
04:48PM	Myriad Genetics (NASDAQ:MYGN) Reports Strong Q2, Stock Jumps 30.6% (StockStory)
04:05PM	Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum (GlobeNewswire)
Aug-03-25 11:13PM	Earnings To Watch: Myriad Genetics (MYGN) Reports Q2 Results Tomorrow (StockStory)
Jul-31-25 08:30AM	Myriad Genetics Announces New $200 Million Credit Facility (GlobeNewswire) -5.19%
Jul-29-25 04:05PM	Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire) -6.39%
02:26PM	Why Myriad Genetics (MYGN) Shares Are Falling Today (StockStory)
04:31AM	North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers (GlobeNewswire)
Jul-15-25 09:00AM	Myriad Genetics Earns 2025 Great Place To Work Certification (GlobeNewswire)
Jul-07-25 09:55AM	Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches (Zacks) -5.54%
Jun-27-25 05:22AM	5 Revealing Analyst Questions From Myriad Genetics's Q1 Earnings Call (StockStory)
Jun-16-25 08:25AM	Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? (Zacks)
Jun-06-25 09:09AM	Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? (Zacks)
12:01AM	3 Reasons to Avoid MYGN and 1 Stock to Buy Instead (StockStory)
Jun-05-25 11:31AM	Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue? (Zacks) -6.99%
Jun-03-25 09:00AM	Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen (GlobeNewswire) +9.42%
Jun-02-25 09:00AM	Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types (GlobeNewswire) +6.44%
May-27-25 07:53PM	Myriad Genetics, Inc. (MYGN) Showcases Breakthrough MRD Data and AI-Driven Cancer Tools at ASCO 2025 (Insider Monkey) +6.14%
04:05PM	Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting (GlobeNewswire)
May-26-25 11:34PM	Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1 (StockStory)

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Phanstiel S. Louise	Director	Feb 26 '26	Buy	4.80	50,407	242,105	233,951	Feb 27 04:46 PM
Phanstiel S. Louise	Director	Feb 27 '26	Buy	4.66	48,000	223,728	281,951	Feb 27 04:46 PM
Phanstiel S. Louise	Director	Feb 25 '26	Buy	4.74	6,100	28,890	183,544	Feb 27 04:46 PM

Open in Screener

BFLY

Butterfly Network Inc

Feb 27 • 04:00PM ET

3.79

-0.88 -18.84 %

Healthcare • Medical Devices • USA • NYSE

BFLY Butterfly Network Inc daily Stock Chart

Peers: ABT GE MRNA TMO PHG HOLX QDEL SONO NTRA TDOC

| Held by: ARKG VTI IWM VXF IWO SCHA VTWO XHE KOMP IHI

Index	RUT	P/E	-	EPS (ttm)	-0.33	Insider Own	23.50%	Shs Outstand	226.11M	Perf Week	27.18%
Market Cap	957.36M	Forward P/E	-	EPS next Y	-0.11	Insider Trans	-3.19%	Shs Float	193.23M	Perf Month	-12.06%
Enterprise Value	834.16M	PEG	-	EPS next Q	-0.04	Inst Own	44.92%	Short Float	12.89%	Perf Quarter	11.80%
Income	-79.87M	P/S	10.82	EPS this Y	-25.00%	Inst Trans	10.92%	Short Ratio	4.18	Perf Half Y	141.40%
Sales	88.45M	P/B	4.70	EPS next Y	28.33%	ROA	-28.77%	Short Interest	24.91M	Perf YTD	-0.26%
Book/sh	0.81	P/C	6.64	EPS next 5Y	-	ROE	-41.42%	52W High	5.03 -24.65%	Perf Year	1.61%
Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	-22.46% 66.40%	ROIC	-35.94%	52W Low	1.32 187.12%	Perf 3Y	70.72%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.46% 15.41%	Gross Margin	43.24%	Volatility	13.84% 8.59%	Perf 5Y	-80.10%
Dividend TTM	-	EV/Sales	9.43	EPS Y/Y TTM	28.91%	Oper. Margin	-91.74%	ATR (14)	0.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.51	Sales Y/Y TTM	16.04%	Profit Margin	-90.31%	RSI (14)	53.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.80	EPS Q/Q	-69.56%	SMA20	11.98%	Beta	2.24	Target Price	5.44
Payout	-	Debt/Eq	0.10	Sales Q/Q	4.51%	SMA50	-0.09%	Rel Volume	2.47	Prev Close	4.67
Employees	190	LT Debt/Eq	0.09	Earnings	Feb 26 BMO	SMA200	49.37%	Avg Volume	5.95M	Price	3.79
IPO	Jul 13, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	55.36% 21.57%	Trades		Volume	14,703,525	Change	-18.84%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-01-25	Downgrade	Oppenheimer	Outperform → Perform
Jul-01-25	Initiated	Craig Hallum	Buy	$3
Mar-17-25	Initiated	William Blair	Outperform
Sep-10-24	Initiated	Lake Street	Buy	$3
Mar-29-23	Initiated	UBS	Neutral	$2.25
Nov-29-22	Initiated	Oppenheimer	Outperform	$4.50
Oct-04-22	Initiated	B. Riley Securities	Buy	$9.50
Dec-17-21	Initiated	UBS	Neutral	$7
Jun-21-21	Initiated	Cowen	Outperform	$20

Today 06:17PM	Butterfly Network Q4 Earnings Call Highlights (MarketBeat) -18.84%
04:22AM	New Strong Sell Stocks for February 27th (Zacks)
Feb-26-26 04:12PM	Butterfly Network Inc (BFLY) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +50.65%
09:45AM	Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Butterfly Network Reports Fourth Quarter 2025 Financial Results (Business Wire)
07:34AM	Loading…
Feb-25-26 07:34AM	Butterfly Network Inc (BFLY) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.08%
Feb-23-26 07:25PM	Claritev Corporation (CTEV) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Feb-17-26 08:05AM	Butterfly Network to Participate at TD Cowen 46th Annual Health Care Conference on March 3, 2026 (Business Wire)
Feb-13-26 11:44AM	Is Butterfly Network (BFLY) One of the Best Strong Buy Penny Stocks to Invest In? (Insider Monkey)
Feb-10-26 09:47AM	Jim Cramer on Butterfly Network (BFLY): "Too Hard for This Guy, Just Too Hard" (Insider Monkey)
08:01AM	Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications (Business Wire)
Feb-03-26 08:01AM	Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (Business Wire)
Jan-27-26 10:14AM	AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market (PR Newswire)
Jan-21-26 08:45AM	Butterfly Network price target raised to $5.50 from $4 at Lake Street (TipRanks) +7.02%
Jan-16-26 11:56AM	Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic (PR Newswire) -8.57%
09:40AM	Loading…
Jan-14-26 09:40AM	Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? (Zacks) +12.50%
Jan-12-26 08:01AM	Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year (Business Wire) +5.69%
Jan-07-26 12:24PM	BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers (Zacks)
Jan-06-26 08:05AM	Butterfly Network to Extend its Proprietary 3D Imaging Capabilities to Butterfly Garden Developers (Business Wire)
Dec-31-25 09:36AM	GlobalFoundries downgraded, TeraWulf upgraded: Wall Street's top analyst calls (The Fly)
Dec-18-25 08:05AM	Butterfly Network to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire) +8.83%
Dec-11-25 11:40PM	Craig-Hallum Maintains a Buy on Butterfly Network (BFLY) (Insider Monkey)
Dec-09-25 09:45AM	Top Insider Purchases in December Signal Market Confidence (24/7 Wall St.)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com) -9.14%
Nov-24-25 07:53AM	TEM vs. BFLY: Which Stock Offers Greater Upside Amid Health Tech Boom? (Zacks) +23.77%
Nov-21-25 08:05AM	Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference (Business Wire) +14.22%
Nov-20-25 01:27AM	Butterfly Network Launches Compass AI: Enterprise Platform to Boost POCUS Documentation Compliance, Revenue (Insider Monkey)
Nov-18-25 11:39AM	BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs (Zacks)
Nov-17-25 08:05AM	Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management (Business Wire) -7.08%
Oct-31-25 03:02PM	Butterfly Network Inc (BFLY) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Inventory ... (GuruFocus.com) +31.86%
11:05AM	Loading…
11:05AM	BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs (Zacks)
06:30AM	Butterfly Network Reports Third Quarter 2025 Financial Results (Business Wire)
Oct-30-25 09:33AM	Earnings To Watch: Butterfly Network Inc (BFLY) Reports Q3 2025 Result (GuruFocus.com) -5.12%
Oct-29-25 08:05AM	Butterfly Network to Participate at UBS Global Healthcare Conference 2025 (Business Wire)
Oct-27-25 08:05AM	Butterfly Network Strengthens Global Information Security Posture with ISO 27001, SOC-2 Type 2, C5 Germany, and NHS DSPT Accreditations (Business Wire)
Oct-23-25 08:30AM	Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market (PR Newswire)
Oct-22-25 09:20AM	BFLY Q3 Earnings Preview: Strategic Progress Likely to Support Growth (Zacks) -5.33%
Oct-17-25 08:05AM	Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025 (Business Wire) -5.36%
Oct-10-25 08:44AM	TEM Expands Partnership With Northwestern Medicine Amid AI Boom (Zacks) -11.28%
Oct-09-25 04:05PM	Butterfly Network Appoints John Doherty as Chief Financial Officer (Business Wire)
Oct-06-25 09:17AM	Zacks.com featured highlights include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network (Zacks) +9.87%
07:45AM	Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health (Business Wire)
Oct-03-25 09:06AM	Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks) +18.88%
Sep-21-25 09:15AM	Butterfly Network Gains Investor Confidence with Record Results (Insider Monkey)
Sep-18-25 04:05PM	Butterfly Network Named to TIME's List of the World's Top HealthTech Companies 2025 (Business Wire) +15.95%
Sep-17-25 02:18PM	TD Cowen Remains Bullish on Butterfly (BFLY), iQ3 Results Bolster Adoption Potential (Insider Monkey)
Sep-12-25 03:35AM	The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM (Zacks)
Sep-11-25 03:00PM	NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy (Zacks)
Sep-09-25 08:00AM	Butterfly Network Appoints Victor Ku as Chief Technology Officer (Business Wire)
Sep-05-25 02:11PM	Rutgers Robert Wood Johnson Medical School Study Published in JAMA Confirms Butterfly-Enabled POCUS Program Heavily Focused on LUNG US with AI Assistance Reduces Stay and Cost (Business Wire)
Aug-26-25 08:54AM	$504 Billion AI Healthcare Revolution Accelerates as Corporate Giants Launch Next-Gen Platforms (PR Newswire)
Aug-25-25 03:00PM	Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now? (Zacks)
Aug-19-25 08:05AM	Butterfly Network Joins Research Project Studying the Impact of AI-Assisted POCUS on Early Tuberculosis Detection in Sub-Saharan Africa (Business Wire)
Aug-17-25 11:41PM	Butterfly Network Advances AI-Powered Ultrasound for Aortic Screening (Insider Monkey)
Aug-13-25 12:08PM	TD Cowen Reiterates a Buy Rating on Butterfly Network (BFLY), Sets a PT of $3.50 (Insider Monkey)
Aug-12-25 09:51PM	Cardiosense appoints John Martin as chief medical officer (MedTech Dive)
11:09AM	Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction (PR Newswire)
Aug-06-25 12:00PM	What Makes Butterfly Network (BFLY) a New Buy Stock (Zacks)
Aug-05-25 08:05AM	Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools (Business Wire)
Aug-02-25 03:06AM	Butterfly Network Inc (BFLY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Aug-01-25 07:47AM	CORRECTING and REPLACING Butterfly Network Reports Second Quarter 2025 Financial Results (Business Wire) -18.13%
07:40AM	Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Butterfly Network Reports Second Quarter 2025 Financial Results (Business Wire)
Jul-31-25 09:30AM	Butterfly Network Inc (BFLY) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com) -5.52%
Jul-18-25 08:05AM	Butterfly Network to Report Second Quarter 2025 Financial Results on August 1, 2025 (Business Wire)
Jul-15-25 09:00AM	Overture Life Appoints Former Butterfly Network Executive Matt Combs as Chief Commercial Officer to Lead Scale-up of IVF Automation Technology as Demand Surges Worldwide (Business Wire)
Jul-02-25 10:07PM	Butterfly Network, Inc. (BFLY) Gains Analyst Confidence Amid EU Review (Insider Monkey)
Jun-09-25 08:00AM	Butterfly Networks RoHS Lead Exemption Revocation Request Progresses to Stakeholder and Consultant Assessment (Business Wire)
Jun-04-25 02:36PM	AI in Healthcare Just Crossed a Tipping Point. Investors Are Watching These Names (PR Newswire)
May-27-25 09:45AM	Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders (PR Newswire) +16.59%
May-26-25 03:00PM	Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy? (Zacks)
May-22-25 08:05AM	Butterfly Network to Participate at William Blair 45th Annual Growth Stock Conference (Business Wire)
May-09-25 04:12AM	Butterfly Network, Inc. (BFLY): Among Billionaire Larry Robbins' Stock Picks with Huge Upside Potential (Insider Monkey)
May-05-25 02:18PM	Butterfly Network: Speculative Potential For This 20% Revenue Grower (Seeking Alpha)
May-02-25 12:00PM	Butterfly Network, Inc. (BFLY) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:40AM	Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Butterfly Network Reports First Quarter 2025 Financial Results (Business Wire)
Apr-22-25 06:47PM	Is Butterfly Network, Inc. (BFLY) the Best Multibagger Penny Stock to Buy According to Billionaires? (Insider Monkey)
08:39AM	Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network (Zacks)
Apr-21-25 05:38AM	3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era (Zacks)
Apr-17-25 04:05PM	Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025 (Business Wire)
Apr-10-25 03:00PM	Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 (Zacks)
Apr-02-25 08:01AM	Butterfly iQ3 Ultrasound Featured in HBO Max's The Pitt Episodes 12 and 13 (Business Wire) +5.41%
Mar-27-25 09:35AM	Down -34.51% in 4 Weeks, Here's Why You Should You Buy the Dip in Butterfly Network (BFLY) (Zacks) -6.15%
Mar-05-25 08:05AM	Butterfly Network to Participate at Oppenheimer 35th Annual Healthcare MedTech & Services Virtual Conference on March 18, 2025 (Business Wire) +5.28%
Feb-28-25 06:30AM	Butterfly Network Reports Fourth Quarter 2024 Financial Results (Business Wire)
Feb-22-25 05:27PM	Butterfly Network, Inc. (BFLY): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:05AM	Butterfly Network to Participate at the TD Cowen 45th Annual Health Care Conference on March 3, 2025 (Business Wire)
Feb-18-25 08:05AM	Butterfly Network to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 (Business Wire)
Jan-29-25 09:10PM	Butterfly Network Announces Pricing of $75.6 million Public Offering of Common Stock (Business Wire) +16.52%
04:01PM	Butterfly Network Announces Proposed Public Offering of Common Stock (Business Wire)
Jan-24-25 07:53PM	Why Is Larry Robbins Bullish on Butterfly Network, Inc. (BFLY) Now? (Insider Monkey) -5.80% -7.44%
Jan-17-25 05:58PM	Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 (PR Newswire) -5.41% +6.54%
Jan-13-25 08:05AM	Butterfly Network and Rutgers Robert Wood Johnson Medical School Reveal Preliminary Findings from Seminal Study on Impact of POCUS in Hospital Care (Business Wire) -6.69%
Jan-08-25 07:00AM	Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2024 Revenue Growth of Approximately 35% Year over Year (Business Wire)
Dec-16-24 08:05AM	Butterfly Network to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +6.19%
Dec-12-24 11:23AM	AI Healthcare Innovations: How They're Shaping the Future for Patients and Investors (PR Newswire)
Nov-11-24 08:05AM	Butterfly Network to Participate at the Virtual BTIG Digital Health Forum on November 25, 2024 (Business Wire)
Nov-08-24 10:25AM	Butterfly Network's iQ3 Honored as the Best Medical Technology at 2024 Prix Galien USA Awards (Business Wire) +6.94%
Nov-07-24 08:05AM	Butterfly Network to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024 (Business Wire)

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cashman Steve	Officer	Feb 26 '26	Proposed Sale	4.35	250,000	1,087,050		Feb 26 04:25 PM
Doherty John N.	EVP, CFO	Jan 07 '26	Sale	3.98	60,182	239,524	1,234,688	Jan 09 04:02 PM
ROTHBERG JONATHAN M	Director	Jan 07 '26	Sale	4.14	452,729	1,874,253	335,834	Jan 08 06:14 PM
ROTHBERG JONATHAN M	Director	Jan 06 '26	Sale	4.03	351,617	1,416,806	788,563	Jan 08 06:14 PM
ROTHBERG JONATHAN M	Director	Jan 08 '26	Sale	4.18	335,834	1,404,525	0	Jan 08 06:14 PM
ROTHBERG JONATHAN M	Director	Jan 08 '26	Proposed Sale	4.18	335,834	1,404,525		Jan 08 04:53 PM
ROTHBERG JONATHAN M	Director	Jan 07 '26	Proposed Sale	4.14	452,729	1,874,253		Jan 07 04:49 PM
Ku Victor	Chief Technology Officer	Jan 05 '26	Sale	3.82	35,968	137,398	811,962	Jan 07 04:06 PM
Doherty John N.	Officer	Jan 07 '26	Proposed Sale	3.98	60,182	239,494		Jan 07 03:13 PM
ROTHBERG JONATHAN M	Director	Jan 06 '26	Proposed Sale	4.03	351,617	1,416,805		Jan 06 05:22 PM
Ku Victor	Officer	Jan 05 '26	Proposed Sale	3.82	35,968	137,416		Jan 05 03:11 PM
ROTHBERG JONATHAN M	Director	Dec 23 '25	Sale	4.01	44,781	179,424	1,157,764	Dec 29 04:05 PM
ROTHBERG JONATHAN M	Director	Dec 26 '25	Sale	4.01	14,911	59,790	1,140,180	Dec 29 04:05 PM
ROTHBERG JONATHAN M	Director	Dec 24 '25	Sale	4.00	2,673	10,692	1,155,091	Dec 29 04:05 PM
ROTHBERG JONATHAN M	Director	Dec 26 '25	Proposed Sale	4.01	14,911	59,790		Dec 29 02:52 PM
ROTHBERG JONATHAN M	Director	Dec 24 '25	Proposed Sale	4.00	2,673	10,692		Dec 29 02:50 PM
ROTHBERG JONATHAN M	Director	Dec 23 '25	Proposed Sale	4.01	44,781	179,424		Dec 23 04:51 PM
ROTHBERG JONATHAN M	Director	Dec 15 '25	Sale	3.16	601,308	1,902,659	196,662	Dec 17 05:56 PM
ROTHBERG JONATHAN M	Director	Dec 16 '25	Sale	3.14	284,986	893,830	0	Dec 17 05:56 PM
Phanstiel S. Louise	Director	Dec 15 '25	Buy	3.08	185,261	571,160	185,261	Dec 17 04:10 PM
ROTHBERG JONATHAN M	Director	Dec 16 '25	Proposed Sale	3.14	284,986	893,830		Dec 16 04:41 PM
ROBBINS LARRY	Director	Dec 11 '25	Buy	3.02	21,370	64,471	14,335,055	Dec 15 06:20 PM
ROTHBERG JONATHAN M	Director	Dec 15 '25	Proposed Sale	3.16	601,308	1,902,658		Dec 15 04:41 PM
ROTHBERG JONATHAN M	Director	Dec 10 '25	Sale	3.13	288,918	905,238	255,976	Dec 12 06:58 PM
ROTHBERG JONATHAN M	Director	Dec 12 '25	Sale	3.08	193,293	595,420	0	Dec 12 06:58 PM
ROTHBERG JONATHAN M	Director	Dec 11 '25	Sale	3.08	123,354	380,128	132,622	Dec 12 06:58 PM
ROTHBERG JONATHAN M	Director	Dec 12 '25	Proposed Sale	3.08	193,293	596,270		Dec 12 04:56 PM
ROTHBERG JONATHAN M	Director	Dec 11 '25	Proposed Sale	3.08	123,354	380,127		Dec 11 04:50 PM
ROTHBERG JONATHAN M	Director	Dec 08 '25	Sale	3.27	769,327	2,517,776	0	Dec 10 08:27 PM
ROTHBERG JONATHAN M	Director	Dec 09 '25	Sale	3.11	176,070	546,768	111,031	Dec 10 08:27 PM
ROTHBERG JONATHAN M	Director	Dec 10 '25	Proposed Sale	3.13	288,918	905,237		Dec 10 05:19 PM
ROTHBERG JONATHAN M	Director	Dec 09 '25	Proposed Sale	3.11	176,070	546,767		Dec 09 05:07 PM
ROTHBERG JONATHAN M	Director	Dec 04 '25	Sale	3.08	64,198	197,473	581,199	Dec 08 08:56 PM
ROTHBERG JONATHAN M	Director	Dec 05 '25	Sale	3.07	37,598	115,591	543,601	Dec 08 08:56 PM
ROTHBERG JONATHAN M	Director	Dec 08 '25	Proposed Sale	3.27	769,327	2,517,776		Dec 08 06:03 PM
ROBBINS LARRY	Director	Dec 03 '25	Buy	2.96	821,648	2,433,639	13,576,792	Dec 05 05:40 PM
ROBBINS LARRY	Director	Dec 04 '25	Buy	2.99	536,893	1,607,833	14,113,685	Dec 05 05:40 PM
ROBBINS LARRY	Director	Dec 05 '25	Buy	3.06	200,000	611,300	14,313,685	Dec 05 05:40 PM
ROTHBERG JONATHAN M	Director	Dec 05 '25	Proposed Sale	3.07	37,598	115,591		Dec 05 04:50 PM
ROTHBERG JONATHAN M	Director	Dec 04 '25	Proposed Sale	3.08	64,198	197,473		Dec 04 04:55 PM
Caezza Nicholas	Deputy General Counsel	Dec 02 '25	Sale	2.83	1,686	4,770	231,035	Dec 04 04:49 PM
ROTHBERG JONATHAN M	Director	Nov 28 '25	Sale	3.08	132,570	408,183	512,827	Dec 02 05:58 PM
Caezza Nicholas	Officer	Dec 02 '25	Proposed Sale	2.83	1,686	4,769		Dec 02 03:11 PM
ROTHBERG JONATHAN M	Director	Nov 28 '25	Proposed Sale	3.08	132,570	408,196		Nov 28 02:16 PM
ROTHBERG JONATHAN M	Director	Nov 24 '25	Sale	3.15	1,110,579	3,498,324	769,814	Nov 26 07:58 PM
ROTHBERG JONATHAN M	Director	Nov 25 '25	Sale	3.27	674,758	2,206,459	544,894	Nov 26 07:58 PM
ROTHBERG JONATHAN M	Director	Nov 26 '25	Sale	3.13	442,539	1,385,147	797,970	Nov 26 07:58 PM
ROTHBERG JONATHAN M	Director	Nov 26 '25	Proposed Sale	3.13	442,539	1,383,598		Nov 26 05:04 PM
ROTHBERG JONATHAN M	Director	Nov 25 '25	Proposed Sale	3.27	674,758	2,206,729		Nov 25 07:09 PM
ROTHBERG JONATHAN M	Director	Nov 24 '25	Proposed Sale	3.15	1,110,579	3,502,988		Nov 24 06:39 PM
ROBBINS LARRY	Director	Nov 20 '25	Buy	2.37	1,000,000	2,366,000	11,955,144	Nov 21 05:35 PM
ROBBINS LARRY	Director	Nov 19 '25	Buy	2.35	1,000,000	2,353,900	10,955,144	Nov 21 05:35 PM
ROBBINS LARRY	Director	Nov 21 '25	Buy	2.58	800,000	2,064,160	12,755,144	Nov 21 05:35 PM
ROTHBERG JONATHAN M	Director	Nov 03 '25	Sale	3.08	100,502	309,345	1,140,007	Nov 05 04:04 PM
Carfora Dawn	Director	Nov 04 '25	Sale	2.69	112,009	301,864	265,505	Nov 05 04:04 PM
Carfora Dawn	Director	Nov 04 '25	Proposed Sale	2.69	100,000	269,140		Nov 04 02:47 PM
Carfora Dawn	Director	Nov 04 '25	Proposed Sale	2.76	12,009	33,145		Nov 04 01:06 PM
ROTHBERG JONATHAN M	Director	Nov 03 '25	Proposed Sale	3.08	100,502	309,366		Nov 03 06:15 PM
Cashman Steve	Chief Business Officer	Sep 04 '25	Sale	1.50	142,590	214,313	2,181,884	Sep 08 04:57 PM
Carlson Megan	Interim CFO	Sep 04 '25	Sale	1.50	13,803	20,746	547,444	Sep 08 04:56 PM
Caezza Nicholas	Deputy General Counsel	Sep 03 '25	Sale	1.52	1,724	2,622	232,721	Sep 05 04:40 PM
Carlson Megan	Officer	Sep 04 '25	Proposed Sale	1.50	13,803	20,740		Sep 04 04:29 PM
Cashman Steve	Officer	Sep 04 '25	Proposed Sale	1.50	142,590	214,256		Sep 04 04:19 PM
Caezza Nicholas	Officer	Sep 03 '25	Proposed Sale	1.52	1,724	2,622		Sep 03 03:23 PM
Cashman Steve	Chief Business Officer	Aug 25 '25	Buy	1.64	50,000	81,953	2,324,474	Aug 27 08:56 AM
Caezza Nicholas	Deputy General Counsel	Aug 04 '25	Sale	1.45	3,118	4,521	234,445	Aug 06 06:09 PM
Getz Heather C	EVP, CFO & COO	May 05 '25	Sale	2.20	65,456	144,069	2,919,274	May 07 04:18 PM
Getz Heather C	Officer	May 05 '25	Proposed Sale	2.20	65,456	144,062		May 05 03:27 PM
DEVIVO JOSEPH	President & CEO	Apr 25 '25	Sale	2.44	320,215	780,684	7,249,789	Apr 29 05:40 PM
DEVIVO JOSEPH	Officer	Apr 25 '25	Proposed Sale	2.44	320,215	780,716		Apr 25 03:41 PM
Stoica Andrei G	Chief Technology Officer	Apr 01 '25	Sale	2.17	1,805	3,908	1,600,182	Apr 03 05:24 PM
Stoica Andrei G	Officer	Apr 01 '25	Proposed Sale	2.17	1,805	3,908		Apr 01 03:25 PM
Stoica Andrei G	Chief Technology Officer	Mar 26 '25	Sale	2.69	3,354	9,016	1,601,987	Mar 28 04:26 PM
Stoica Andrei G	Officer	Mar 26 '25	Proposed Sale	2.69	3,354	9,017		Mar 26 03:17 PM

MYGN

Myriad Genetics, Inc

BFLY

Butterfly Network Inc

Upgrade your FINVIZ experience